Literature DB >> 17109495

mRNA expression, functional profiling and multivariate classification of colon biopsy specimen by cDNA overall glass microarray.

Orsolya Galamb1, Ferenc Sipos, Elek Dinya, Sandor Spisak, Zsolt Tulassay, Bela Molnar.   

Abstract

AIM: To understand the local pathophysiological alterations and gene ontology-based functional classification of colonic biopsies into inflammatory and neoplastic diseases.
METHODS: Total RNA was extracted from frozen biopsies and amplified by T7-method. Expression profile was evaluated by Atlas Glass 1K microarrays. After microarray quality control, applicable data were available from 10 adenomas, 6 colorectal adenocarcinomas (CRCs), and 6 inflammatory bowel diseases (IBDs). Multivariate statistical and cell functional analyses were performed. Real-time RT-PCR and immunohistochemistry were used for validation.
RESULTS: Discriminant analysis of selected genes, could correctly reclassify all 22 samples using 4 parameters (heat shock transcription factor-1, bystin-like, calgranulin-A, TRAIL receptor 3). IBD samples were characterized by overregulated chemokine (C-X-C motif) ligand 13, replication protein A1, E74-like factor 2 and downregulated TNF receptor-associated factor 6, BCL2-interacting killer genes. In adenomas upregulation of TNF receptor-associated factor 6, replication protein A1, E74-like factor 2 and underexpression of BCL2-associated X protein, calgranulin-A genes were found. CRC cases had significantly increased epidermal growth factor receptor, topoisomerase-1, v-jun, TNF receptor-associated factor 6 and TRAIL receptor 3, and decreased RAD51 and RAD52 DNA repair gene, protein phosphatase-2A and BCL2-interacting killer mRNA levels. Epidermal growth factor receptor RT-PCR and immunohistochemistry, topoisomerase-1 RT-PCR confirmed the chip results.
CONCLUSION: Different histological alterations can be reclassified by functional, multivariate analysis using cDNA microarrays. Further studies with expanded sample number are needed for subclassification of pathological alterations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17109495      PMCID: PMC4087344          DOI: 10.3748/wjg.v12.i43.6998

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  45 in total

1.  Expression profiling of gastric adenocarcinoma using cDNA array.

Authors:  W El-Rifai; H F Frierson; J C Harper; S M Powell; S Knuutila
Journal:  Int J Cancer       Date:  2001-06-15       Impact factor: 7.396

2.  Amplified RNA synthesized from limited quantities of heterogeneous cDNA.

Authors:  R N Van Gelder; M E von Zastrow; A Yool; W C Dement; J D Barchas; J H Eberwine
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

3.  Analysis of the gene-expression profile regarding the progression of human gastric carcinoma.

Authors:  Masaki Mori; Koshi Mimori; Yasuji Yoshikawa; Kenji Shibuta; Tohru Utsunomiya; Noriaki Sadanaga; Fumiaki Tanaka; Ayumi Matsuyama; Hiroshi Inoue; Keizo Sugimachi
Journal:  Surgery       Date:  2002-01       Impact factor: 3.982

Review 4.  Heat shock protein expression and immunity: relevance to gynecologic oncology.

Authors:  S S Witkin
Journal:  Eur J Gynaecol Oncol       Date:  2001       Impact factor: 0.196

5.  Interleukin-7 receptor expression and activation in nonhaematopoietic neoplastic cell lines.

Authors:  Larry Cosenza; Gullu Gorgun; Alexander Urbano; Francine Foss
Journal:  Cell Signal       Date:  2002-04       Impact factor: 4.315

6.  Significance of the expression of the growth factor pleiotrophin in pancreatic cancer patients.

Authors:  Hans-Jürgen Klomp; Oliver Zernial; Sabine Flachmann; Anton Wellstein; Hartmut Juhl
Journal:  Clin Cancer Res       Date:  2002-03       Impact factor: 12.531

7.  Dysregulation of apoptosis is a major mechanism in the lymph node involvement in colorectal carcinoma.

Authors:  Eva Bandres; Victoria Catalan; Iosu Sola; Beatriz Honorato; Elena Cubedo; Lucia Cordeu; Esther Andion; Alvaro Escalada; Ruth Zarate; Esteban Salgado; Natalia Zabalegui; Fermin García; Jesus Garcia-Foncillas
Journal:  Oncol Rep       Date:  2004-08       Impact factor: 3.906

8.  Induction of HSF1 expression is associated with sporadic colorectal cancer.

Authors:  Hui Cen; Shu Zheng; Yong-Ming Fang; Xiao-Ping Tang; Qi Dong
Journal:  World J Gastroenterol       Date:  2004-11-01       Impact factor: 5.742

9.  Identification of genes uniquely involved in frequent microsatellite instability colon carcinogenesis by expression profiling combined with epigenetic scanning.

Authors:  Yuriko Mori; Jing Yin; Fumiaki Sato; Anca Sterian; Lisa A Simms; Florin M Selaru; Karsten Schulmann; Yan Xu; Andreea Olaru; Suna Wang; Elena Deacu; John M Abraham; Joanne Young; Barbara A Leggett; Stephen J Meltzer
Journal:  Cancer Res       Date:  2004-04-01       Impact factor: 12.701

10.  Loss of detoxification in inflammatory bowel disease: dysregulation of pregnane X receptor target genes.

Authors:  Thomas Langmann; Christoph Moehle; Richard Mauerer; Michael Scharl; Gerhard Liebisch; Alexandra Zahn; Wolfgang Stremmel; Gerd Schmitz
Journal:  Gastroenterology       Date:  2004-07       Impact factor: 22.682

View more
  6 in total

1.  The behavior of matrix metalloproteinase-9 in lymphocytic colitis, collagenous colitis and ulcerative colitis.

Authors:  Gábor Lakatos; Ferenc Sipos; Pál Miheller; István Hritz; Mária Zsófia Varga; Márk Juhász; Béla Molnár; Zsolt Tulassay; László Herszényi
Journal:  Pathol Oncol Res       Date:  2011-06-16       Impact factor: 3.201

2.  Clinical utility of measuring expression levels of Stanniocalcin 2 in patients with colorectal cancer.

Authors:  Shahryar Hashemzadeh; Amir Ahmad Arabzadeh; Mehrdad Asghari Estiar; Masoud Sakhinia; Nahid Mesbahi; Leila Emrahi; Morteza Ghojazadeh; Ebrahim Sakhinia
Journal:  Med Oncol       Date:  2014-09-19       Impact factor: 3.064

Review 3.  Escaping cell death via TRAIL decoy receptors: a systematic review of their roles and expressions in colorectal cancer.

Authors:  Kelly Xue Jing Jong; Elsa Haniffah Mejia Mohamed; Zaridatul Aini Ibrahim
Journal:  Apoptosis       Date:  2022-10-07       Impact factor: 5.561

4.  Modeling oncogenic signaling in colon tumors by multidirectional analyses of microarray data directed for maximization of analytical reliability.

Authors:  Magdalena Skrzypczak; Krzysztof Goryca; Tymon Rubel; Agnieszka Paziewska; Michal Mikula; Dorota Jarosz; Jacek Pachlewski; Janusz Oledzki; Jerzy Ostrowski; Jerzy Ostrowsk
Journal:  PLoS One       Date:  2010-10-01       Impact factor: 3.240

Review 5.  Targeting DNA damage response in cancer therapy.

Authors:  Noriko Hosoya; Kiyoshi Miyagawa
Journal:  Cancer Sci       Date:  2014-03-21       Impact factor: 6.716

6.  Identification of unique gene expression profile in children with regressive autism spectrum disorder (ASD) and ileocolitis.

Authors:  Stephen J Walker; John Fortunato; Lenny G Gonzalez; Arthur Krigsman
Journal:  PLoS One       Date:  2013-03-08       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.